
Please try another search
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. Beijing Tiantan Biological Products Co., Ltd. was founded in 1966 and is headquartered in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Cui Yulin | - | - | Director |
Daoxing Fu | 57 | 2017 | MD & Director |
Huichuan Yang | 54 | 2016 | Director |
Xiaoming Yang | 59 | 2015 | Chairman |
Ligang Hu | 47 | 2015 | Director |
Xiangrong Li | 51 | 2018 | Director |
Jian Chen | 52 | 2023 | Chairman of the Supervisory Board |
Yanlin He | 57 | 2023 | Deputy GM & Director |
Jianming Wang | 53 | 2020 | Employee Supervisor |
Hui Chuan Yang | 56 | 2014 | Chairman of the Board |
Yana Liu | 49 | 2020 | Deputy GM & Director |
Yan Fang | 56 | 2020 | Independent Director |
Fenling Gu | 61 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review